The Safety and Pharmacokinetics Study of TAKC-02 Inhalation Solution in Healthy Adult Males.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

December 28, 2021

Study Completion Date

December 28, 2021

Conditions

Healthy Volunteer

Interventions

DRUG

TAKC-02

Inhalation Solution

DRUG

Placebo

Inhalation Solution

Trial Locations (1)

TAKC-02 Study Site, Tokyo

All Listed Sponsors

lead

TAK-Circulator Co.

INDUSTRY

NCT05018533 - The Safety and Pharmacokinetics Study of TAKC-02 Inhalation Solution in Healthy Adult Males. | Biotech Hunter | Biotech Hunter